CNE000000KV1
CNE000000KV1
NANJING PHARMACEUTICAL GP CO LT
Loading chart...
Elevated Business & Solvency Risk
Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 45/100).
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.2x).
Beta (Market Relation)
0.2x
DefensiveVolatility (5Y p.a.)
28.3% p.a.
5-Year HorizonMax Drawdown (5Y)
-36.9%
5-Year HorizonSharpe Ratio
-0.01
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +3.6% |
| 3 Years | 26.5% | -28.3% | -0.06 | +0.9% |
| 5 Years | 28.3% | -36.9% | -0.01 | +2.2% |
| 10 Years | 26.4% | -56.6% | -0.29 | -5.2% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (28.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -56.6% in the extended horizon.